A new version of the Australian Therapeutic Goods Advertising Code (TGAC) has come into force from 1 January 2022. The TGAC sets out the requirements for advertising therapeutic goods to the general public. The new version supersedes version (02) 2018 with a transition period of six months, ending 30 June 2022. During the transition period Sponsors (MA holders) may comply with either the 2022 or the 2018 versions.
The new TGAC contains a number of improvements, including:
- simplification of the language and structure of the Code to improve readability, reduce complexity and therefore increase overall compliance
- revision and streamlining the mandatory statements required to be included in advertisements about therapeutic goods
- clarification of the requirements relating to testimonials and endorsements about therapeutic goods
- expanding the types of therapeutic goods that may be offered as a sample.
There is an Explanatory Statement document available at the URL provided. The TGA will be running webinars in January and February 2022 to guide advertisers and sponsors through the new TGAC.
Need to know more about regulation changes in Australia? Get in touch with RegASK’s experts.
Contact RegASK for more details Read more
